India allows emergency use of two vaccines for U-12 children
Drugs Controller General of India (DCGI) authorized the emergency use of two Covid-19 vaccines for children under the age of […]
Say something
Serum, Bharat Biotech coronavirus vaccines get emergency use approval
India’s central drug authority Drugs Controller General of India (DCGI) has given formal approval to the Oxford-AstraZeneca and Bharat Biotech […]
Oxford vaccine may be the first to get regulator’s approval: Report
As India prepares to start vaccination drive against COVID-19 in couple of weeks, most probably in January next year, all […]
SII seeks emergency use authorisation for ‘Covishield’ in India
The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation […]
Bharat biotech’s Covaxin gets DCGI nod for phase 3 clinical trial
The Drugs Controller General of India (DCGI) has given approval to ‘Covaxin’ for phase 3 clinical trials with certain conditions. […]
Zenara Pharma gets DCGI approval to manufacture and sell Favipiravir tablets
Hdyerabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that it has received approval from the […]
Biocon drug for COVID 19 ALZUMAb® (Itolizumab) to cost Rs 7,950 per vial
Biocon Ltd, an innovation-led global biopharmaceuticals company, presenting its key insights into the results of the Itolizumab for treating patients […]
COVID-19: Biocon’s medical device gets DCGI nod to treat critical patients
The Drugs Controller General of India (DCGI) has given go-ahead to a medical device of Biocon Biologics to treat critical […]
Advanced Therapy for Treating Hepatitis C
Biocon has launched advanced novel therapy for the treatment of Hepatitis C at a lower price. CIMIVIR-L, a fixed dose […]
-
-
Flipkart Health+ App Launched
06-04-2022
